|
WO2018099600A1
|
|
A method for polyalkoxylation of nucleic acids that enables recovery and reuse of excess polyalkoxylation reagent
|
|
EP3443095A1
|
|
Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors
|
|
AU2015268717A1
|
|
Lipid binding nucleic acids
|
|
US2017166604A1
|
|
Methods for the preparation of a polyalkoxylated nucleic acid molecule
|
|
EP3071702A1
|
|
Synthesis of l-nucleic acids by means of an enzyme
|
|
US2017233737A1
|
|
Means and Methods for the Treatment of Nephropathy
|
|
CN104379748A
|
|
Enzymatic synthesis of l-nucleic acids
|
|
BR112014016877A2
|
|
c5a-binding nucleic acids
|
|
AU2013209130A1
|
|
Nucleic acids specifically binding CGRP
|
|
AU2013200034A1
|
|
Sdf-i binding nucleic acids
|
|
SG11201401362TA
|
|
Glucagon binding nucleic acids
|
|
AU2012241062A1
|
|
Novel use of spiegelmers
|
|
AU2012216540A1
|
|
Ghrelin binding nucleic acids
|
|
AU2012200147A1
|
|
Method for producing conjugates of polysaccharides and polynucleotides
|
|
AU2012206750A1
|
|
Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
|
|
EP2633053A1
|
|
Use of hepcidin binding nucleic acids for depletion of hepcidin from the body
|
|
SG188220A1
|
|
Sdf-1 binding nucleic acids and the use thereof in cancer treatment
|
|
WO2012025251A1
|
|
Nucleic acids for treatment of chronic complications of diabetes
|
|
WO2011131371A1
|
|
Lipid binding nucleic acids
|
|
TW201103549A
|
|
Hepcidin binding nucleic acids
|
